Back to today’s briefing

Story perspectives

Personalized Screening Fails to Boost Cancer Diagnoses, Study Shows

2/12/2026

22 2 Full Breakdown

Summary

Story summary

Dr. Laura Esserman, a breast cancer surgeon, started the WISDOM study in 2016 to test personalized, risk-based screening.
The December results show personalized screening did not increase cancer diagnoses compared with standard annual screenings across populations.
The results support Esserman's call for risk-based screening by showing reduced advanced stage 2B cancers.

1 of 1

Story summary

Dr. Laura Esserman, a breast cancer surgeon, started the WISDOM study in 2016 to test personalized, risk-based screening.
The December results show personalized screening did not increase cancer diagnoses compared with standard annual screenings across populations.
The results support Esserman's call for risk-based screening by showing reduced advanced stage 2B cancers.